With the worldwide spread of the Coronavirus supply chains are currently partially interrupted, which leads to bottlenecks in production. In various European countries, 3D printing companies founded platforms to use additive manufacturing processes to create missing components, for example for ventilators produce and thus support the medical technology companies. Open source documents - for example for the 3D printing of protective face masks - were developed, made available online and serve as the basis for component production. The European Commissionon last week called on research clusters to report their 3D printers and get involved in the production of the materials they need.
Together with DRESDEN-concept and other partners builds biosaxony is currently setting up a network of 3D printing service providers throughout Saxony to supply clinics and other healthcare providers with the materials that are currently missing. The origin of the idea is the biosaxony accelerator team next3D about Dr. Ronny Grunert, which already supplies the pharmacy of the University Hospital Leipzig with urgently needed caps and sampling tubes using 3D printing technology.
Together with researchers from the medical faculty of the University of Dresden, the Helmholtz Center Dresden-Rossendorf, the Leibnitz Institute for Polymer Research e. V. and other research institutions are currently printing face protection visors for local hospitals. biosaxony coordinates the demand query, while DRESDEN-concept monitors the utilization of the printer capacities. More than 50 3D printers are now integrated here, with which almost 1.000 visor mounts can be produced per week. Orders from hospitals, care facilities and other healthcare providers are currently in the four-digit range, so that a scale-up is already being intensively considered.
Our special thanks also go to the companies involved, above all Spezi-Pack Karl Spethmann GmbH from Klingenberg and its managing director, Mr. Walters, who provided the visor plates free of charge.
Numerous companies inside and outside the network are converting their production so that delivery bottlenecks in the healthcare system can be eliminated. If you would like to be one of them, we look forward to hearing from you firstname.lastname@example.org, so that we can include you in our future reporting.